UNSPSC 51332006: Paliperidone palmitate

This classification denotes a serotonin antagonist and dopamine antagonist and antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8P8USM8FR. European Medicines Agency schedules Paliperidone palmitate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31687. Paliperidone palmitate generally arises in the molecular formula C39H57FN4O4. The term 'paliperidone palmitate' is a United States Adopted Name designation.

Most nations, for tariff and trade purposes, schedule paliperidone palmitate under HS 29349990 and SITC 51579. As of Q4 2014, PALIPERIDONE PALMITATE remains US FDA's Preferred Term for this commodity. Paliperidone palmitate bears US NLM identifiers UMLS ID C2719626 and NCI Concept Code C83917. SMILES: CCCCCCCCCCCCCCCC(=O)OC1CCCN2C1NC(C(C2=O)CCN3CCC(CC3)C4C5CCC(CC5ON4)F)C.

UNSPSC 51332006 Paliperidone palmitate is a Commodity code used by state and local health agencies to procure injectable antipsychotic medications and related pharmaceutical products. However, the recent state and local contracting activity associated with this code shows a significant mismatch: the single opportunity posted under it concerns naloxone (an opioid overdose reversal agent) and drug deactivation systems, which fall outside the code's nominal pharmaceutical scope and suggest a tagging or classification error rather than authentic paliperidone procurement. The available record does not demonstrate active, ongoing solicitation of paliperidone palmitate by state or local governments.

Seminole County, Florida, issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB required electronic submission through the county's e-Procurement Portal with a response deadline of July 26, 2023—a date that predates the posting date by several years, indicating a data quality issue in the source record. Vendors must meet standard state compliance requirements including drug-free workplace certification, E-Verify compliance, and specified insurance coverages. The contract carries an initial two-year term with one-year renewal option and is subject to FEMA-funded compliance requirements. Because the code's nominal commodity and the recent opportunity are unrelated, firms interested in state and local pharmaceutical procurement should verify the correct UNSPSC classification with customer procurement offices rather than rely on this code as a reliable procurement signal for paliperidone palmitate or similar injectable antipsychotics.